Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder

Summary

This study proposes to recruit patients with Opioid Use Disorder (OUD) seeking treatment into our program of outpatient detoxification and naltrexone induction followed by a relapse-prevention treatment with Extended release-naltrexone (XR-NTX) . Eligible participants will be randomly assigned to adjunctive treatment with lorcaserin (N = 40), or placebo (N = 20) with weekly therapy.

Timeline

Start

2017-05-25

Primary completion

2019-08-30

Completion

2019-08-30

Drugs

Indications